Nan Fung Group Holdings’s Galera Therapeutics, Inc. Common Stock GRTX Stock Holding History

Nan Fung Group Holdings’s Portfolio GRTX Stock Details GRTX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-613,223	Closed	-$85.9K	–	47
2024 Q1	$85.9K	Hold	613,223	–	–	0.08%	45
2023 Q4	$89.2K	Hold	613,223	–	–	0.06%	35
2023 Q3	$107K	Hold	613,223	–	–	0.09%	35
2023 Q2	$1.91M	Hold	613,223	–	–	1.22%	16
2023 Q1	$1.57M	Hold	613,223	–	–	1.07%	19
2022 Q4	$914K	Hold	613,223	–	–	0.63%	22
2022 Q3	$1.07M	Hold	613,223	–	–	0.68%	19
2022 Q2	$797K	Hold	613,223	–	–	0.55%	21
2022 Q1	$1.46M	Hold	613,223	–	–	0.69%	18
2021 Q4	$2.81M	Hold	613,223	–	–	0.83%	17
2021 Q3	$4.97M	Hold	613,223	–	–	1.59%	10
2021 Q2	$6.03M	Buy	+613,223	New	+$4.98M	1.87%	7

Other funds holding GRTX

XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return

Nan Fung Group Holdings's GRTX Position: Q2 2024 in Review

Nan Fung Group Holdings sold out of Galera Therapeutics, Inc. Common Stock (GRTX) in Q2 2024, closing a stake of 613,223 shares — an estimated $85.9K sold.

Nan Fung Group Holdings first reported a position in GRTX in Q2 2021 and held it in 12 quarters. The position peaked at $6.03M in Q2 2021. 1 fund tracked by Wall St. Rank holds GRTX as of Q2 2024.

Nan Fung Group Holdings reported no remaining Galera Therapeutics, Inc. Common Stock position as of Q2 2024 after selling out during the quarter.
Nan Fung Group Holdings sold 613,223 Galera Therapeutics, Inc. Common Stock shares in Q2 2024, an estimated $85.9K.
Nan Fung Group Holdings first reported a position in Galera Therapeutics, Inc. Common Stock in Q2 2021 and held it in 12 quarters.
Nan Fung Group Holdings's Galera Therapeutics, Inc. Common Stock position peaked at $6.03M in Q2 2021.
1 fund tracked by Wall St. Rank held Galera Therapeutics, Inc. Common Stock as of Q2 2024.

Based on Nan Fung Group Holdings's 13F filing for Q2 2024, filed 13 Aug 2024.